[CAS NO. 1009816-48-1]  Thiamet G

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1009816-48-1]

Catalog
SLK-S7213
Brand
Selleck
CAS
1009816-48-1

DESCRIPTION [1009816-48-1]

Overview

MDLMFCD15144964
Molecular Weight248.3
Molecular FormulaC9H16N2O4S
SMILESO[C@H]1[C@H](O)[C@@]2([H])N=C(NCC)S[C@@]2([H])O[C@@H]1CO

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM4.0274 mL20.1369 mL40.2739 mL
5 mM0.8055 mL4.0274 mL8.0548 mL
10 mM0.4027 mL2.0137 mL4.0274 mL
50 mM0.0805 mL0.4027 mL0.8055 mL

Description

Thiamet G is a potent, selective inhibitor with of 21 nM, while exhibiting 37,000-fold selectivity over human lysosomal –hexosaminidase.

Targets

O-GlcNAcase [1]
(cell-free assay)
21 nM(Ki)

In vitro

In NGF-differentiated PC-12 cells, inhibition of O-GlcNAcase by Thiamet G increases the cellular levels of O-GlcNAc with EC50 of approximately 30 nM. Thiamet G (100 mM) reduces tau phosphorylation by approximately 2.1-fold, 2.7-fold, 1.2-fold and 1.3-fold for Ser396, Thr231, Ser422 and Ser262, respectively. Thiamet G (12.5 nM and 25 nM) significantly enhances p38 phosphorylation by increasing O-GlcNAcylation in mesangial cells. In O-GlcNAc transferase or O-GlcNAcase gain of function cells, thiamet-G restores the assembly of the spindle and partially rescues histone phosphorylation.

In vivo

In rats, thiamet G (50 mg/kg) administrated by i.v. crosses the blood brain barrier and then results in increase in brain O-GlcNAc levels in a dose- and time-dependent manner, and reduction of tau phosphorylation in rat brain. Thiamet G is also orally bioavailable. O-GlcNAc accumulation induced by thiamet G stimulates chondrogenic differentiation in C57/bl mice by increasing the gene expression of differentiation markers, as well as the activity of MMP-2 and -9.